Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

The urgent need for vaccines against Ebola virus (EBOV) was underscored by the large outbreak in West Africa (2014–2016). Since then, several promising vaccine candidates have been tested in pre-clinical and clinical studies. As a result, two vaccines were approved for human use in 2019/2020, of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kupke, Alexandra, Dietzel, Erik, Schmidt, Jörg, Shams-Eldin, Hosam, Sauerhering, Lucie, Krähling, Verena, Gellhorn Serra, Michelle, Eickmann, Markus, Becker, Stephan
Aineistotyyppi: Artikkeli
Kieli:englanti
Julkaistu: Philipps-Universität Marburg 2023
Aiheet:
correlates of protection; nucleoprotein
vaccine
Modified Vaccinia virus Ankara
Ebola virus
glycoprotein
Medizin
Medical sciences Medicine
Linkit:PDF-kokoteksti
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
No citations were found for this record.

Samankaltaisia teoksia